< Back to companies
Biolexis
Lehi, Utah, United States
Screening each Moleculern™ fragment against a curated protein target library has resulted in 600K real/empirical data points and scaffold-like compounds that can be used to design new drug candidates and to accelerate the discovery process.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- biolexistx.com/
Categories
Drug DiscoveryBiotechPreclinical Development
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of Biolexis?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now